Judson Englert
Hoofd Techniek/Wetenschap/O&O bij CYTEIR THERAPEUTICS, INC.
Actieve functies van Judson Englert
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2020 | - |
Loopbaan van Judson Englert
Eerdere bekende functies van Judson Englert
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Medimmune, Inc. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Judson Englert
| University of Pittsburgh | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Beurs
- Insiders
- Judson Englert
- Ervaring
